@SECGov Just another layer of defense for Nancy Pelosi and her husband’s insider trading scheme… it’s disgusting how incredibly corrupt the #SEC is and it just gets worse with that puppet Gensler in charge.
@coinbase@digitalassetbuy@SECGov@faryarshirzad So now you want to fight the SEC??? Where were you spineless cowards when they sued @Ripple over $XRP??? Had you stepped up two years ago, you might not be in the situation you find yourselves in now… instead you delist $XRP and now the SEC comes after YOU TOO! Sorry, not sorry.
@digitalassetbuy I have a serious question… if the exchanges run out of $XRP and therefore can no longer list it, where do we go when the time comes to sell some of our XRP? Will the exchanges still buy retail holder’s $XRP??? Do we sell directly to institutions??? How would that work?
Ask yourself this question:
Why would the @SEC_Enforcement object or get involved in this subpoena?
Clayton and his new employer are part of the private sector. @Ripple served a subpoena on them. I’m pretty sure that One River has lawyers that can move to quash the subpoena.
@DrHOSP1@Ripple Are you implying that he is not long XRP? Lol. He also said that he wants everyone to rise. Clarity for the whole space is key to that. Can the Bitcoin maxis say that?! Short answer... NO. I love how Bitcoin maxis take a small piece and shift it to fit their narrative, lol
@GodfatherCap @JamesKrilich I'm not suggesting anything... I am saying there will be a conversion factor if we are bought by a pharma company... THAT'S ALL. This whole thing is being blown way out of proportion. I personally hope that we are able to grow without being bought out... time will tell.
@GodfatherCap @JamesKrilich I’m talking about a buyout... which is where this conversation started. If ENZC is trading at .10/share and the company buying them out is at $100/share it would be a 1000:1 conversion to new company’s shares. Again, this is just an example. Not saying that’s going to be the case
@JamesKrilich I hope you are right and that ENZC has every pharma and bio-pharma company knocking at their door trying to get in. At that point, we are all millionaires and can buy matching yachts, lol.
@JamesKrilich I agree with you 100%. That is why I have a large position in $ENZC and will continue to buy the dips. I got in when the price was at .059 and didn't even think about selling when we rose into the .90's, so I am definitely long on the company and believe in what they are doing.
@fancybrownsugar @JamesKrilich It really depends on what the price per share of the company that is buying us is and what premium that company is willing to pay for the ENZC shares... That calculation would determine the split.
@fancybrownsugar @JamesKrilich It was a hypothetical... obviously, I don't know what the split would be because I don't know the company who is buying (or would buy) ENZC... it could be a 100:1, 500:1 or 1000:1 split.
@TORPEDO871 That is a good plan. So basically, you're saying they're not selling, they are partnering or licensing their research, correct? The only problem with that is that pharma companies are greedy and want it all or they will burry what they can't have. I work in pharma, I know...